ECO Animal Health Group (LON:EAH) Stock Passes Below Two Hundred Day Moving Average – Here’s What Happened

ECO Animal Health Group plc (LON:EAH) crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of GBX 83.84 ($1.04) and traded as low as GBX 63 ($0.78). ECO Animal Health Group shares last traded at GBX 63 ($0.78), with a volume of 35,282 shares traded.

Analyst Upgrades and Downgrades

Separately, Shore Capital reaffirmed a “buy” rating on shares of ECO Animal Health Group in a research note on Friday, November 29th.

ECO Animal Health Group Stock Performance

The company has a debt-to-equity ratio of 4.31, a current ratio of 2.96 and a quick ratio of 2.14. The stock has a market capitalization of £42.68 million, a PE ratio of 3,150.00 and a beta of -0.05. The firm has a fifty day moving average price of GBX 67.78 and a two-hundred day moving average price of GBX 83.84.

ECO Animal Health Group (LON:EAH) last released its earnings results on Thursday, November 28th. The company reported GBX (2.50) (($0.03)) earnings per share for the quarter. ECO Animal Health Group had a return on equity of 2.13% and a net margin of 1.17%.

Insiders Place Their Bets

In other ECO Animal Health Group news, insider David Hallas purchased 15,500 shares of ECO Animal Health Group stock in a transaction dated Monday, December 2nd. The stock was acquired at an average price of GBX 74 ($0.92) per share, for a total transaction of £11,470 ($14,269.72). 21.65% of the stock is currently owned by company insiders.

ECO Animal Health Group Company Profile

ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.

Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.

Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.